Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare.

× No keyword cloud information.

5 in total

Review 1. Criteria influencing the clinical uptake of pharmacogenomic strategies.

Authors: Jai Shah
Journal: BMJ Date: 2004-06-19

Review 2. Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.

Authors: Marc Maliepaard; Charity Nofziger; Marisa Papaluca; Issam Zineh; Yoshiaki Uyama; Krishna Prasad; Christian Grimstein; Michael Pacanowski; Falk Ehmann; Silvia Dossena; Markus Paulmichl
Journal: Nat Rev Drug Discov Date: 2013-02 Impact factor: 84.694

Review 3. Bridging the Gaps in Personalized Medicine Value Assessment: A Review of the Need for Outcome Metrics across Stakeholders and Scientific Disciplines.

Authors: William S Bush; Jessica N Cooke Bailey; Mark F Beno; Dana C Crawford
Journal: Public Health Genomics Date: 2019-08-27 Impact factor: 2.000

Review 4. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.

Authors: Katherine I Morley; Wayne D Hall
Journal: J Mol Med (Berl) Date: 2003-11-04 Impact factor: 4.599

Review 5. Can the Spanish care system assume the new costs of medications against cancer?

Authors: Carlos Camps; Cristina Caballero; Rafael Sirera; Ana Blasco; Diego Cayuela; Mireia Gil; Xavier Badía
Journal: Clin Transl Oncol Date: 2008-02 Impact factor: 3.405

5 in total